You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | 0.0% | -780.0% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -4.0 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 0.0 | 21.4 |
| Price / Book value | 1.2 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2019-03-31 | n/a | -3.12 | -2.70p | -7.1 | 0.0 | n/a | n/a | 0.0% |
| 2020-03-31 | n/a | -3.17 | -2.07p | -1.7 | 0.0 | n/a | n/a | 0.0% |
| 2021-03-31 | 0.19 | -3.21 | -1.82p | -4.1 | 0.0 | n/a | n/a | 0.0% |
| 2022-03-31 | n/a | -3.17 | -0.99p | -3.5 | 0.0 | n/a | n/a | 0.0% |
| Evgen Pharma doses first volunteers in SFX-01 trial Sharecast News | 16 Nov |
|---|---|
| Evgen starts recruiting volunteers for trial of lead asset Sharecast News | 12 Oct |
| Notice of Results | 26-May-23 19:28 |
|---|---|
| Preliminary results from Phase 1b study | 22-Mar-23 14:38 |
| Price Monitoring Extension | 16-Mar-23 23:47 |
| Second Price Monitoring Extn | 16-Mar-23 20:31 |
| Price Monitoring Extension | 16-Mar-23 20:24 |